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Objectives: The aim of the present work is the valorization of squid pens 
through the production of chitosan that can be used for the development of bio-
medical applications. The present work is focused on β-chitin extraction from 
squid pens of the species Dosidicus gigas and its further conversion into chito-
san. The biomedical potential of the isolated squid chitosan was assessed by 
processing this polymer as scaffolds for tissue engineering strategies. 
Methods: Alkali solution was used to deproteinized squid pens and thus isolate 
β-chitin, which was further converted into chitosan through a deacetylation re-
action. The chitosan scaffolds were developed using a freeze-drying process, 
from 3% and 4% chitosan solutions in acetic acid and freezing at temperatures 
of -80ºC and -196ºC. Chitosan scaffolds were neutralized using two different 
methods: M1 – NaHO solution; and M2 – ethanol/water and NaHO solution. 
Morphology, Mechanical properties, degradation, cytotoxicity (L929 cells) and 
cellular adhesion (ATDC5 Chondrocytes like cells) of squid chitosan scaffolds 
were assessed and compared with the properties of scaffolds produced with 
commercial chitosan. 
Results: The morphology of scaffolds revealed a lamellar structure for all pro-
duced scaffolds, independent of the origin and concentration of chitosan. The 
treatment with sodium hydroxide and ethanol caused the formation of larger 
pores and loose of some lamellar features. Different freezing temperatures gave 
different pore morphology and the lower temperature a smaller pore size. The 
in vitro cell culture and cell adhesion studies showed that all chitosan scaffolds 
exhibited a non-cytotoxic effect over the mouse fibroblast-like cell line, L929 
cells. 
Conclusions: The chitosan produced from the endoskeletons of giant squid 
Dosidicus Gigas has proven to be a valuable alternative to the commercial one 
when considering its use as biomaterial for different biomedical applications.
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Objectives: Low back pain is a common disease in modern society. One major 
reason is the degeneration of the nucleus pulposus (NP, part of the intervertebral 
disc). The regeneration of nucleus pulposus via cell therapy requires a biocom-
patible matrix, which facilitates the differentiation of hMSCs (human mesenchy-
mal stem cells) to nucleus pulposus cells. The enzyme transglutaminase was 
found to be suitable to generate a gelatine matrix by cross-linking and could be 
utilized to immobilize hMSCs. Further natural ECM of the NP should be used for 
crosslinking and immobilization. 
Methods: The immobilized cells were cultivated for 21 days in media, contain-
ing growth and differentiation factors. Cells were seeded at a density of 4x106 
cells per cm³, equal to the density in the NP. Viability of the cells in the gelatine 
matrix was proofed by using a tetrazolium salt (WST-1). At certain dates RNA 
isolation was done following the phenol/guanidine isothiocyanate protocol. RNA 
was transformed into cDNA followed by a RT-PCR with a gel electrophoresis af-
terwards. Different primers were used to analyze the successful differentiation of 
hMSC-TERT into nucleus pulposus cells. In further analysis, NP extract isolated 
from pigs, has been added to the gelatine matrix. 
Results: The viability of the immobilized cells has been on a constant value 
over the differentiation period of 21 days. Thus, the survival of hMSC-TERT in 
gelatine is proofed. The differentiation status of hMSC-TERT in the two different 
matrices (gelatine, NP extract) could be analyzed. 
Conclusions: Data concerning the differentiation of hMSC-TERT in nucleus 
pulposus cells in a gelatin matrix and differences between the two matrices will 
be presented.
Conclusions: The in ovo quantification method was more complex as com-
pared to ex ovo. The results indicate that no differences exist between the hy-
drogels tested in what concerns to their angiogenic potential.
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Objectives: Following the green chemistry philosophy, this work aims at de-
signing and developing new 3D architectures of natural-based polymers, com-
bining ionic liquids (ILs) and supercritical fluid technology, with relevant applica-
tions in tissue engineering and regenerative medicine. With this purpose, SPCL, 
a polymeric blend of starch, which is one of the most abundantly occurring 
natural polymers and poly(ε-caprolactone), a synthetic biodegradable polymer, 
was processed by supercritical fluid foaming, at different operating conditions. 
The use of this technique for processing natural-based polymers has been lim-
ited due to the fact that they are normally semi-crystalline polymers. This can be 
overcome by the use of ILs, which have recently been proposed as plasticizing 
agents of starch. 
Methods: The IL tested in this work was 1-butyl-3-methylimidazolium acetate 
and its plasticizing effect was demonstrated by the mechanical tests conducted. 
The production of porous and interconnected structures was carried out, here-
after, using CO2 as foaming agent. The effect of different operating variables, 
such as pressure, temperature and contact time on the porosity, interconnectiv-
ity and pore size distribution of the matrixes was evaluated and the morphology 
was analyzed by micro-computed tomography. 
Results and Discussion: The results obtained suggest that the induction of 
porosity within the constructs depends largely on the diffusion of CO2 in the 
matrix, which explains the higher porosity of the samples processed at higher 
pressures and larger contact times. Moreover, the presence of IL has been 
shown to have a key role in the success of the supercritical foaming process, 
and consequently on the preparation of porous and interconnected scaffolds. 
Conclusions: To our knowledge it is the first time that this approach has been 
reported. The findings described in this work can be extended and adapted to 
other raw materials, which largely broads the spectrum of natural-based poly-
mers that may be processed into 3D porous matrixes.
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Objectives: Poly(l-lactide) (PLLA), poly(glycolide) (PGA), poly(ethylene glycol) 
(PEG) and/or copolymers of these have extensively been used in medicine for 
applications. VICRYL® is a commercially available suture produced from a copo-
lymer of glycolide/lactide (90/10 mol/mol). In this study, Vicryl® fibers were used 
for increasing mechanical properties of PLLA-PEG cryostructures. 
Methods: PLLA-PEG block copolymer was synthesized by ring opening polym-
erization of L-lactide dimer and PEG (6000 Da). Wet spun fibers were obtained 
from chitosan solution in acetic acid. Commercially available Vicryl® was used 
as a source of Poly(lactide-co-glycolide) (PLGA) fibers. PLGA fibers with varying 
length (1, 2 and 4mm) and matrix/fiber ratios (2:1, 3:1 and 4:1) were dispersed 
in % 5 (w/v) solutions of PLLA-PEG in 1,4 Dioxane. Porous scaffolds were pre-
pared with these solutions under cryotropic conditions (-12°C). 
Results: FTIR, and NMR spectra confirmed the chemical structure of PLLA–
PEG copolymer. Cryostructures made from this copolymer had interconnect-
ed macropores, which were obtained. They exhibited remarkable properties, 
including high flexibility and rapid size change to external forces, and also 
‘‘swellability’’ in aqueous media. Vicryl fibers (both the amount and the fiber as-
pect ratio) increased the mechanical strength of the PLLA-PEG cryostructures 
quite significantly. 
Conclusions: PLLA-PEG cryostructures reinforced with vicryl fibers were con-
cluded to be a good candidate that can be used in tissue engineering applica-
tions for both hard and soft tissue regeneration.
